NorthWest Biotherapeutics Inc (NWBO)

[The Danish Dude]

Nice found by @bio99



https://www.gov.uk/government/news/uk-to-introduce-first-of-its-kind-framework-to-make-it-easier-to-manufacture-innovative-medicines-at-the-point-of-care

https://www.gov.uk/government/consultations/point-of-care-consultation/consultation-on-point-of-care-manufacturing



PIM = Promising Innovative Medicine of which DCVax-L was the first awarded in the UK.







UK UK UK and UK. Two excerpts:

The framework will apply to all POC products manufactured in the UK, including a range of advanced therapy medicinal products, including cell therapy, gene therapy and tissue engineered products.

This proposed framework will ensure that the UK is a favourable location to develop and trial novel medicines by supporting advancing technologies and manufacturing. manufacture advanced technology products and conduct clinical trials

While we await the APPGBT report by Hugh Adams, who we know was and is the one facilitating NWBO having met british politicians and have been promoting DCVax-L at the All-Party Parliamentary Group on Brain Tumours (APPGBT) in the UK.

Writing the #APPGBT report has been the focus of my week but find out what the rest of the team has been up to in this week's #braintumour campaigning blog for @braintumourrsch https://t.co/bmZhCKjleO pic.twitter.com/MqlIeo9RtW

— Hugh Adams (@hugh1eadams) January 20, 2023

For me, this week (and without doubt the next few weeks) can be summed up with two words – ‘The Report.’

Concerned about the lack of progress in improving options and outcomes for brain tumour patients and their families, the All-Party Parliamentary Group on Brain Tumours (APPGBT) launched the ‘Pathway to a Cure – breaking down the barriers’ inquiry in 2021. During 2022 the APPGBT held six oral evidence sessions and received survey responses from 38 leading brain tumour scientists and clinicians across the UK representing 26 organisations. Representations were also taken from the pharmaceutical industry, charitable funders and convening bodies. As many of you will know, because you submitted your own evidence, the inquiry undertook a patient survey too.

I have written about this many times over the past twelve months, Brain Tumour Research provide the secretariat for the APPGBT, and the upshot of all the written and oral evidence that has been read, heard and collated is ‘The Report’.

The report launch will be on Tuesday 28th February where the recommendations reached by the panel will be made public. Yesterday we had a meeting with our Chair Derek Thomas MP to hone down these recommendations and in a couple of weeks the whole inquiry panel will meet to agree the final contents.